J&J and Astel­las pile on two more bio­phar­ma in­dus­try law­suits over CMS drug price ne­go­ti­a­tions

John­son & John­son and Astel­las are join­ing with their phar­ma heavy­weight peers Bris­tol My­ers Squibb, Mer­ck, in­dus­try group PhRMA and the US Cham­ber of Com­merce …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER